THKLY Quote, Financials, Valuation and Earnings

Kubota has a net margin of 2.32% compared to THK's net margin of 6.75%. THK's return on equity of 3.53% beat Kubota's return on equity of 9.86%.

THK has a consensus price target of --, signalling downside risk potential of --. On the other hand Kubota has an analysts' consensus of -- which suggests that it could grow by 27.29%. Given that Kubota has higher upside potential than THK, analysts believe Kubota is more attractive than THK.

THK has a beta of 0.856, which suggesting that the stock is 14.365% less volatile than S&P 500. In comparison Kubota has a beta of 0.963, suggesting its less volatile than the S&P 500 by 3.749%.

THK has a quarterly dividend of $0.43 per share corresponding to a yield of 3.82%. Kubota offers a yield of 2.58% to investors and pays a quarterly dividend of $0.82 per share. THK pays 39.92% of its earnings as a dividend. Kubota pays out 24.99% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

THK quarterly revenues are $574.1M, which are smaller than Kubota quarterly revenues of $4.7B. THK's net income of $13.3M is lower than Kubota's net income of $317.2M. Notably, THK's price-to-earnings ratio is 35.34x while Kubota's PE ratio is 9.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for THK is 1.37x versus 0.75x for Kubota. Usually stocks with elevated PS ratios are considered overvalued.

Kyocera has a net margin of 2.32% compared to THK's net margin of -3.6%. THK's return on equity of 3.53% beat Kyocera's return on equity of 1.45%.

THK has a consensus price target of --, signalling downside risk potential of --. On the other hand Kyocera has an analysts' consensus of $11.40 which suggests that it could fall by -2.36%. Given that Kyocera has higher upside potential than THK, analysts believe Kyocera is more attractive than THK.

THK has a beta of 0.856, which suggesting that the stock is 14.365% less volatile than S&P 500. In comparison Kyocera has a beta of 0.241, suggesting its less volatile than the S&P 500 by 75.921%.

THK has a quarterly dividend of $0.43 per share corresponding to a yield of 3.82%. Kyocera offers a yield of 2.75% to investors and pays a quarterly dividend of $0.17 per share. THK pays 39.92% of its earnings as a dividend. Kyocera pays out 73.91% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

THK quarterly revenues are $574.1M, which are smaller than Kyocera quarterly revenues of $3.2B. THK's net income of $13.3M is higher than Kyocera's net income of -$116.4M. Notably, THK's price-to-earnings ratio is 35.34x while Kyocera's PE ratio is 51.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for THK is 1.37x versus 1.21x for Kyocera. Usually stocks with elevated PS ratios are considered overvalued.

SBC Medical Group Holdings has a net margin of 2.32% compared to THK's net margin of 5.34%. THK's return on equity of 3.53% beat SBC Medical Group Holdings's return on equity of 25.89%.

THK has a consensus price target of --, signalling downside risk potential of --. On the other hand SBC Medical Group Holdings has an analysts' consensus of $10.00 which suggests that it could grow by 221.54%. Given that SBC Medical Group Holdings has higher upside potential than THK, analysts believe SBC Medical Group Holdings is more attractive than THK.

THK has a beta of 0.856, which suggesting that the stock is 14.365% less volatile than S&P 500. In comparison SBC Medical Group Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

THK has a quarterly dividend of $0.43 per share corresponding to a yield of 3.82%. SBC Medical Group Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. THK pays 39.92% of its earnings as a dividend. SBC Medical Group Holdings pays out -- of its earnings as a dividend. THK's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

THK quarterly revenues are $574.1M, which are larger than SBC Medical Group Holdings quarterly revenues of $53.1M. THK's net income of $13.3M is higher than SBC Medical Group Holdings's net income of $2.8M. Notably, THK's price-to-earnings ratio is 35.34x while SBC Medical Group Holdings's PE ratio is 7.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for THK is 1.37x versus 1.43x for SBC Medical Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.

SECOM has a net margin of 2.32% compared to THK's net margin of 9.53%. THK's return on equity of 3.53% beat SECOM's return on equity of 7.56%.

THK has a consensus price target of --, signalling downside risk potential of --. On the other hand SECOM has an analysts' consensus of -- which suggests that it could fall by --. Given that THK has higher upside potential than SECOM, analysts believe THK is more attractive than SECOM.

THK has a beta of 0.856, which suggesting that the stock is 14.365% less volatile than S&P 500. In comparison SECOM has a beta of 0.351, suggesting its less volatile than the S&P 500 by 64.883%.

THK has a quarterly dividend of $0.43 per share corresponding to a yield of 3.82%. SECOM offers a yield of 1.76% to investors and pays a quarterly dividend of $0.08 per share. THK pays 39.92% of its earnings as a dividend. SECOM pays out 39.71% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

THK quarterly revenues are $574.1M, which are smaller than SECOM quarterly revenues of $2B. THK's net income of $13.3M is lower than SECOM's net income of $190.3M. Notably, THK's price-to-earnings ratio is 35.34x while SECOM's PE ratio is 20.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for THK is 1.37x versus 2.73x for SECOM. Usually stocks with elevated PS ratios are considered overvalued.